Page 1 of Clinical Trials for Chiesi Farmaceutici S.p.A. [SPONSOR-COLLABORATORS], 59 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Last Updated: August 24, 2010
Condition(s): Chronic Obstructive Pulmonary Disease
2
Completed
Dose Finding Study of CHF 4226 for Treating Patients With COPD
Last Updated: August 24, 2010
Condition(s): Chronic Obstructive Pulmonary Disease
3
Completed
Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers
Last Updated: March 26, 2009
Condition(s): Chronic Obstructive Pulmonary Disease
4
Completed
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration
Last Updated: December 14, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
5
Not yet recruiting
Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5992 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD
Last Updated: April 27, 2012
Condition(s): Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
6
Completed
Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers
Last Updated: April 2, 2012
Condition(s): COPD
7
Not yet recruiting
Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate
Last Updated: November 23, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
8
Completed
Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients
Last Updated: February 14, 2012
Condition(s): Asthma
9
Completed
Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
Last Updated: July 5, 2007
Condition(s): Bronchial Asthma
10
Completed
Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
Last Updated: April 21, 2010
Condition(s): Bronchial Asthma
11
Completed
Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients
Last Updated: December 22, 2010
Condition(s): Asthma
12
Completed
Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma
Last Updated: May 4, 2011
Condition(s): Asthma
13
Completed
A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients.
Last Updated: November 16, 2011
Condition(s): Asthma
14
Completed
Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics
Last Updated: February 14, 2012
Condition(s): Asthma
15
Completed
Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices
Last Updated: December 21, 2011
Condition(s): Asthma
16
Recruiting
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
Last Updated: March 28, 2012
Condition(s): Asthma
17
Completed
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Last Updated: April 21, 2010
Condition(s): Asthma
18
Completed
Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Last Updated: December 12, 2011
Condition(s): Chronic Obstructive Pulmonary Disease
19
Completed
Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)
Last Updated: April 5, 2012
Condition(s): Respiratory Distress Syndrome, Newborn
20
Recruiting
Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Last Updated: November 15, 2011
Condition(s): Postmenopausal Osteoporosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Chiesi+Farmaceutici+S.p.A.

Page 1 of Clinical Trials for Chiesi Farmaceutici S.p.A. [SPONSOR-COLLABORATORS], 59 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About